Efficacy, predictability and safety of long-term orthokeratology: An 18-year follow-up study

角膜塑形术 正视 医学 入射(几何) 视力 眼科 人口统计学的 折射误差 角膜 人口学 物理 社会学 光学
作者
Joan Gispets,Pilar Yébana,Núria Lupón,Genı́s Cardona,Joan Pérez-Corral,Jaume Pauné,Bernat Cortilla
出处
期刊:Contact Lens and Anterior Eye [Elsevier BV]
卷期号:45 (1): 101530-101530 被引量:22
标识
DOI:10.1016/j.clae.2021.101530
摘要

To determine the efficacy, predictability and safety of long-term orthokeratology in children and adults.Case histories of 300 orthokeratology patients (596 eyes; 34.3% children; 65.7% adults) were reviewed to collect information on demographics, corneal and refractive parameters, visual acuity, residual refraction and adverse effects. Predictability was defined as the percentage of eyes with absolute values of spherical equivalent refraction ≤ 0.5 D of emmetropia, and efficacy as the ratio of post-orthokeratology uncorrected and pre-orthokeratology corrected distance visual acuity.Median duration of treatment was 37 and 28.5 months in children and adults, respectively (p = 0.022). During the first year, 17.2% of children and 33% of adults ceased lens wear (p < 0.001). For children and adults with a successful ortho-k treatment of at least one year of duration, 88.7% and 95.9% of eyes had a predictable refractive outcome, and efficacy was 0.98 and 1.01, respectively. A larger percentage of children (65.7%) were free of complications than of adults (55.4%) (p = 0.015). One event of microbial keratitis occurred in adults (6.8 cases per 10,000 patient-years) and none in children. Corneal staining was the most frequent complication, with a higher incidence in adults (p = 0.007) and in higher myopia (p < 0.001), higher anterior corneal eccentricity (p = 0.019) and smaller anterior horizontal radius (p = 0.027).Orthokeratology is a safe and predictable long-term procedure in children and adults, with a low incidence of serious adverse effects. Corneal staining episodes are relatively frequent throughout the course of the treatment, thus highlighting the relevance of education of experienced users.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
Giogle完成签到,获得积分10
刚刚
刚刚
1秒前
Evina发布了新的文献求助10
2秒前
2秒前
雪媚娘完成签到,获得积分10
2秒前
2秒前
孤独蛋挞完成签到,获得积分10
3秒前
3秒前
3秒前
3秒前
doudouhhr完成签到,获得积分10
3秒前
zzk完成签到,获得积分10
4秒前
4秒前
拾光完成签到,获得积分10
4秒前
涵张发布了新的文献求助10
5秒前
6秒前
6秒前
6秒前
充电宝的应助被倾夏唯音采纳,获得10
6秒前
无花果的应助被li5498693采纳,获得10
6秒前
鸭爪爪完成签到,获得积分10
7秒前
jynihao发布了新的文献求助10
7秒前
诚心山芙完成签到,获得积分10
7秒前
7秒前
内向傲旋发布了新的文献求助10
8秒前
coach发布了新的文献求助10
8秒前
8秒前
湘崽丫发布了新的文献求助10
8秒前
huhuhu完成签到,获得积分20
9秒前
所所的应助被在读芝士青年采纳,获得10
9秒前
无花果的应助被FionaZhong采纳,获得10
9秒前
wanci的应助被yy采纳,获得10
10秒前
chenxin7271发布了新的文献求助10
11秒前
11秒前
丘比特的应助被qweqwe采纳,获得10
12秒前
只只发布了新的文献求助10
12秒前
唐圜发布了新的文献求助10
12秒前
内向傲旋完成签到,获得积分10
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Energie-Contracting 1500
Mathematical models in hydrology 1000
Klimaschutzrecht durch den Energiesektor im Mehrebenensystem – Ein Rechtsvergleich 1000
Oncology Clinical Trials: Successful Design, Conduct, and Analysis, Second Edition 800
Erzählte Gnade 500
Butadiene hydroxytelechelic oligomers PBHT 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8083110
求助须知:如何正确求助?哪些是违规求助? 9498282
关于积分的说明 21405934
捐赠科研通 7651330
什么是DOI,文献DOI怎么找? 3402142
关于科研通互助平台的介绍 2531149
邀请新用户注册赠送积分活动 2440811